Oxford Biomedica raises £60m to bolster US capacity
By Benjamin Chiou
Date: Friday 15 Aug 2025
(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.
A total of 12.21m shares were placed at a price of 431p each, slightly below Thursday's closing price of 439.50p, while certain existing shareholders subscribed for 1.71m shares.
In total, the placing and subscription represented 13.1% of the issued share capital of the company.
OXB said the net proceeds from the fundraising would go towards expanding its US commercial-scale capacity and advancing process quality, productivity and yields.
"This will allow the Company to address growing client demand including visible near and medium-term opportunities across all clinical phases, including late-stage and commercial supply," OXB said.
Shares were up 1.9% at 447.83p by 0919 BST.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN